Multiple Sclerosis Trial, Recruiting NCT07096700 Sponsor: Azienda Usl di Bologna Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT07096700
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a confirmed diagnosis of multiple sclerosis
  • People aged between 18 and 65 years old
  • People of any sex
  • People who score above 100 on a cognitive assessment tool used specifically for multiple sclerosis, called the BICAMS (confirm with trial site)
  • People whose level of physical disability falls within a specific range on a standard MS disability scale called the EDSS, scoring between 3 and 6 (confirm with trial site)
  • People who score 46 or higher on the Berg Balance Scale, a test that measures balance and fall risk (confirm with trial site)
  • People for whom a doctor has determined that a wearable gait-assistance device called the Exoband orthosis is appropriate
  • People who score 20 or below on the physical part of a fatigue questionnaire called the Modified Fatigue Impact Scale (confirm with trial site)
  • People who have signed a form giving their informed consent to take part

Who may not be able to join:

  • People who have severe vision or hearing problems
  • People who have had a multiple sclerosis relapse (a flare-up of symptoms) within the past 3 months
  • People who have severe anxiety or depression
  • People who have severe muscle stiffness or fixed joint tightening in the lower limbs
  • People who experience motion sickness symptoms when using virtual reality technology

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Loredana Sabattini, IRCCS Istituto delle Scienze Neurologiche di Bologna - AUSL of Bologna

Phone: +390514966403

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Azienda Usl di Bologna
Registry
ClinicalTrials.gov
Start date
2 March 2026
Est. completion
1 June 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Score of the standardized tests and gait parameters

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov